Skip to main content
SpringerLink
Log in

Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice

  • Protein Processing And Trafficking, Pain, Depression, And Anxiety
  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Understanding the role of neuropeptides in mediating emotional behaviors is an important avenue for discovering novel drug targets for anxiety disorders. A role for galanin in mediating anxiety-related behavior is suggested by the pattern of distribution in the CNS and the coexistence of galanin with norepinephrine in the locus coeruleus. Studies in rats have shown that central administration of galanin modulates anxiety-related behaviors, and galanin release blocks the proanxiety effects of noradrenergic activation in prestressed rats. To further investigate the role of galanin in anxiety behaviors, we conducted a comprehensive behavioral phenotyping of galanin overexpressing transgenic mice (GAL-tg). GAL-tg mice were normal on measures of general health, neurological reflexes, home cage social behaviors, sensory functions, motor coordination, and exploratory locomotor activity. In three separate tests for anxiety-related behaviors, the elevated plus-maze, light ↔ dark exploration, and open field center time, GAL-tg mice showed no anxiety-like phenotype. GAL-tg mice and wildtype littermate controls were equally responsive to the anxiolytic effects of chlordiazepoxide (10 mg/kg) in the light ↔ dark exploration test, indicating normal benzodiazepine receptor function in GAL-tg mice. Stimulation of noradrenergic cells via administration with an α2 adrenoreceptor antagonist, yohimbine (2.5 mg/kg), produced proanxiety effects in wild type mice in the light ↔ dark exploration test, but not in the GAL-tg mice. These data suggest that galanin contributes to the modulation of anxiety states induced by high levels of noradrenergic activation, but is silent under less challenging situations. A specific role for galanin in extreme anxiety states represents an attractive target for the development of novel anxiolytic treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aggleton J. P. (1993) The contribution of the amygdala to normal and abnormal emotional states. Trends Neurosci. 16, 328–333.

    Article  PubMed  CAS  Google Scholar 

  • American Psyciatric Association (1994) DSM-IV, American Psychiatric Press, Washington DC.

    Google Scholar 

  • Austin M. C., Cottingham S. L., Paul S. M., and Crawley J. N. (1990) Tyrosine hydroxylase and galanin mRNA levels in locus coeruleus neurons are increased following reserpine administration. Synapse 6, 351–357.

    Article  PubMed  CAS  Google Scholar 

  • Bale T. L., Contarino A., Smith G. W., et al. (2000) Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat. Genet. 24, 410–414.

    Article  PubMed  CAS  Google Scholar 

  • Bale T. L., Picetti R., Contarino A., et al. (2001) Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J. Neurosci. 22, 193–199.

    Google Scholar 

  • Bartfai T., Fisone G., and Langel Ü. (1992) Galanin and galanin antagonists: molecular and biochemical perspectives. Trends Pharmacol. Sci. 13, 312–317.

    Article  PubMed  CAS  Google Scholar 

  • Beal M. F., Clevens R. A., Chattha G. K., MacGarvey U. M., Mazurek M. F., and Gabriel S. M. (1988) Galaninlike immunoreactivity is unchanged in Alzheimer’s disease and Parkinson’s disease dementia cerebral cortex. J. Neurochem. 51, 1935–1941.

    Article  PubMed  CAS  Google Scholar 

  • Belzung C., Le Guisquet A. M., and Crestani F. (2000) Flumazenil induces benzodiazepine partial agonist-like effects in BALB/c but not C57BL/6 mice. Psychopharmacology 148, 24–32.

    Article  PubMed  CAS  Google Scholar 

  • Benzing W. C., Kordower J. H., and Mufson E. J. (1993) Galanin immunoreactivity within the primate basal forebrain: evolutionary change between monkeys and apes. J. Comp. Neurol. 336, 31–39.

    Article  PubMed  CAS  Google Scholar 

  • Bing O., Möller C., Engel J. A., Soderpal B., and Heilig M. (1993) Anxiolytic-like action of centrally administered galanin. Neurosci. Lett. 164, 17–20.

    Article  PubMed  CAS  Google Scholar 

  • Blakeman K. H., Holmberg K., Hao J. X., et al. (2001) Mice over-expressing galanin have elevated heat nociceptive threshold. Neuroreport 12, 423–425.

    Article  PubMed  CAS  Google Scholar 

  • Bloch G. J., Butler P. C., and Kohlert J. G. (1996) Galanin microinjected into the medial preoptic nucleus facilitates female- and male-typical sexual behaviors in the female rat. Physiol. Behav. 59, 1147–1154.

    Article  PubMed  CAS  Google Scholar 

  • Bloch G. J., Butler P. C., Eckersell C. B., and Mills R. H. (1998) Gonadal steroid-dependent GAL-IR cells within the medial preoptic nucleus (MPN) and the stimulatory effects of GAL within the MPN on sexual behaviors. Ann. N. Y. Acad. Sci. 863, 188–205.

    Article  PubMed  CAS  Google Scholar 

  • Bowser R., Kordower J. H., and Mufson E. J. (1997) A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer’s disease. Brain Pathol. 7, 723–730.

    PubMed  CAS  Google Scholar 

  • Branchek T. A., Smith K. E., Gerald I., and Walker M. W. (2000) Galanin receptor subtypes. Trends Pharmacol. Sci. 21, 109–117.

    Article  PubMed  CAS  Google Scholar 

  • Branchek T., Smith K. E., and Walker M. W. (1998) Molecular biology and pharmacology of galanin receptors. Ann. N. Y. Acad. Sci. 863, 94–107.

    Article  PubMed  CAS  Google Scholar 

  • Bremner J. D., Krystal J. H., Southwick S. M., and Charney D. S. (1996a) Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse 23, 28–38.

    Article  PubMed  CAS  Google Scholar 

  • Bremner J. D., Krystal J. H., Southwick S. M., and Charney D. S. (1996b) Noradrenergic mechanisms in stress and anxiety: II. Clinical studies. Synapse 23, 39–51.

    Article  PubMed  CAS  Google Scholar 

  • Ceresini G., Marchini L., Fabbo A., et al. (1997) Evaluation of circulating galanin levels after exercise-induced pituitary hormone secretion in man. Metabolism 46, 282–286.

    Article  PubMed  CAS  Google Scholar 

  • Chan-Palay V. (1998) Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer’s and Parkinson’s disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J. Comp. Neurol. 273, 543–557.

    Article  Google Scholar 

  • Chan-Palay V. (1991) Alterations in the locus coeruleus in dementias of Alzheimer’s and Parkinson’s disease. Prog. Brain. Res. 88, 625–630.

    Article  PubMed  CAS  Google Scholar 

  • Cheung C. C., Hohmann J. G., Clifton D. K., and Steiner R. A. (2001) Distribution of galanin messenger RNA-expressing cells in murine brain and their regulation by leptin in regions of the hypothalamus. Neuroscience 103, 423–432.

    Article  PubMed  CAS  Google Scholar 

  • Cole J. C., Burroughs G. J., Laverty C. R., Sheriff N. C., Sparham E. A., and Rodgers R. J. (1995) Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against alpha 2-adrenoceptor mediation. Psychopharmacology 118, 425–436.

    Article  PubMed  CAS  Google Scholar 

  • Consolo S., Baldi G., Russi G., Civenni G., Bartfai T., and Vezzani A. (1994) Impulse flow dependency of galanin release in vivo in the rat ventral hippocampus. Proc. Natl. Acad. Sci. USA 91, 8047–8051.

    Article  PubMed  CAS  Google Scholar 

  • Contarino A., Heinrichs S. C., and Gold L. H. (1999) Understanding corticotropin releasing factor neurobiology: contributions from mutant mice. Neuropeptides 33, 1–12.

    Article  PubMed  CAS  Google Scholar 

  • Cortes R., Ceccatelli S., Schalling M., and Hökfelt T. (1990) Differential effects of intracerebroventricular colchicine administration on the expression of mRNAs for neuropeptides and neurotransmitter enzymes, with special emphasis on galanin: an in situ hybridization study. Synapse 6, 369–391.

    Article  PubMed  CAS  Google Scholar 

  • Corwin R. L., Robinson J. K., and Crawley J. N. (1993) Galanin antagonists block galanin-induced feeding in the hypothalamus and amygdala of the rat. Eur. J. Neurosci. 5, 1528–1533.

    Article  PubMed  CAS  Google Scholar 

  • Crabbe J. C., Wahlsten D., and Dudek B. C. (1999) Genetics of mouse behavior: interactions with laboratory environment. Science 284, 670–672.

    Article  Google Scholar 

  • Crawley J. N. (1981) Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol. Biochem. Behav. 15, 695–699.

    Article  PubMed  CAS  Google Scholar 

  • Crawley J. N. (1999a) Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res. 835, 18–26.

    Article  PubMed  CAS  Google Scholar 

  • Crawley J. N. (1999b) The role of galanin in feeding behavior. Neuropeptides 33, 369–375.

    Article  PubMed  CAS  Google Scholar 

  • Crawley J. N. (2000) What Wrong with My Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice, Wiley-Liss, New York.

    Google Scholar 

  • Crawley J. N., Austin M. C., Fiske S. M., et al. (1990) Activity of centrally administered galanin fragments on stimulation of feeding behavior and on galanin receptor binding in the rat hypothalamus. J. Neurosci. 10, 695–3700.

    Google Scholar 

  • Crawley J. N. and Goodwin F. K. (1980) Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol. Biochem. Behav. 13, 167–170.

    Article  PubMed  CAS  Google Scholar 

  • Crawley J. N. and Paylor R. (1997) A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Horm. Behav. 31, 197–211.

    Article  PubMed  CAS  Google Scholar 

  • Crawley J. N., Robinson J. K., Langel Ü., and Bartfai T. (1993) Galanin receptor antagonists M40 and C7 block galanin-induced feeding. Brain Res. 600, 268–272.

    Article  PubMed  CAS  Google Scholar 

  • Davis M. (1997) Neurobiology of fear responses: the role of the amygdala. J. Neuropsychiatry Clin. Neurosci. 9, 382–402.

    PubMed  CAS  Google Scholar 

  • Degli Uberti E. C., Ambrosio M. R., Bondanelli M., et al. (1995) Human galanin reduces plasma norepinephrine levels in man. J. Clin. Endocrinol. Metab. 80, 1894–1898.

    Article  PubMed  CAS  Google Scholar 

  • Diaz-Cabiale Z., Narvaez J. A., Garcia-Coronel M., and Fuxe K. (2001) Galanin/alpha2-adrenoceptor interactions in telencephalic and diencephalic regions of the rat. Neuroreport 12, 151–155.

    Article  PubMed  CAS  Google Scholar 

  • Diaz-Cabiale Z., Narvaez J. A., Marcos P., et al. (1998) Galanin and NH2-terminal galanin fragments in central cardiovascular regulation. Ann. N. Y. Acad. Sci. 863, 421–424.

    Article  PubMed  CAS  Google Scholar 

  • Edwards A. V., Jarhult J., Anderson P.-O., and Bloom S. R. (1982) The importance of the pattern of stimulation in relation to the response of automatic effectors, in Systemic Role of Regulatory Peptides, Bloom, S. R. and Polak J. M. (eds.), Lindenlaub., Schattauer, Stuttgart, pp. 145–148.

    Google Scholar 

  • Fathi Z., Cunningham A. M., Iben L. G., et al. (1997) Cloning, pharmacological characterization and distribution of a novel galanin receptor. Brain Res. Mol. Brain Res. 51, 49–59.

    Article  PubMed  CAS  Google Scholar 

  • Foster O. J., Chowdrey H. S., Larsen P. J., and Lightman S. L. (1992) Differential regulation of tyrosine hydroxylase, neuropeptide Y and galanin gene expression in the pons and medulla oblong at a following chronic oral administration of 2% saline: a combined in situ hybridisation and immunohistochemical study. Neuroendocrinology 55, 544–551.

    PubMed  CAS  Google Scholar 

  • Gentleman S. M., Falkai P., Bogerts B., Herrero M. T., Polak J. M., and Roberts G. W. (1989) Distribution of galanin-like immunoreactivity in the human brain. Brain Res. 505, 311–315.

    Article  PubMed  CAS  Google Scholar 

  • Gray T. S. and Magnuson D. J. (1987) Galanin-like immunoreactivity within amygdaloid and hypothalamic neurons that project to the midbrain central grey in rat. Neurosci. Lett. 83, 264–268.

    Article  PubMed  CAS  Google Scholar 

  • Griebel G. (1999) Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders? Pharmacol. Ther. 82, 1–61.

    Article  PubMed  CAS  Google Scholar 

  • Gustafson E. L., Smith K. E., Durkin M. M., Gerald C., and Branchek T. A. (1996) Distribution of a rat galanin receptor mRNA in rat brain. Neuroreport 7, 953–957.

    Article  PubMed  CAS  Google Scholar 

  • Hasenohrl R. U., Souza-Silva M. A., Nikolaus S., et al. (2000) Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery. Neuropeptides 34(5), 272–280.

    Article  PubMed  CAS  Google Scholar 

  • Hedlund P. B. and Fuxe K. (1996) Galanin and 5-HT1A receptor interactions as an integrative mechanism in 5-HT neurotransmission in the brain. Ann. N.Y. Acad. Sci. 780, 193–212.

    Article  PubMed  CAS  Google Scholar 

  • Heilig M. and Widerlov E. (1995) Neurobiology and clinical aspects of neuropeptide Y. Crit. Rev. Neurobiol. 9, 115–136.

    PubMed  CAS  Google Scholar 

  • Hogg S. A. (1996) Review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol. Biochem. Behav. 54, 21–30.

    Article  PubMed  CAS  Google Scholar 

  • Hökfelt T., Millhorn D., Seroogy K., et al. (1987) Coexistence of peptides with classical transmitters. Experientia 43, 768–780.

    Article  PubMed  Google Scholar 

  • Hökfelt T., Bartfai T., and Crawley J.N. (1998a) Galanin: Basic research discoveries and therapeutic implications. Ann. N. Y. Acad. Sci. 863, xiii-xiv.

    Article  Google Scholar 

  • Hökfelt T., Xu Z. Q., Shi T. J., Holmberg K., and Zhang X. (1998b) Galanin in ascending systems. Focus on coexistence with 5-hydroxytryptamine and noradrenaline. Ann. N. Y. Acad. Sci. 863, 252–263.

    Article  PubMed  Google Scholar 

  • Holets V. R., Hökfelt T., Rokaeus A., Terenius L., and Goldstein, M. (1988) Locus coeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus. Neuroscience 24, 893–906.

    Article  PubMed  CAS  Google Scholar 

  • Holmes A. (2001) Targeted gene mutation approaches to the study of anxiety-like behavior in mice. Neurosci. Biobehav. Rev. 25, 261–273.

    Article  PubMed  CAS  Google Scholar 

  • Holmes P. V., Blanchard D. C., Blanchard R. J., Brady L. S., and Crawley J. N. (1995) Chronic social stress increases levels of preprogalanin mRNA in the rat locus coeruleus. Pharmacol. Biochem. Behav. 50, 655–660.

    Article  PubMed  CAS  Google Scholar 

  • Holmes P. V. and Crawley J. N. (1995) Coexisting neurotransmitters in central noradrenergic neurons, In Psychopharmacology: The Fourth Generation of Progress (Bloom F. E. and Kupfer D. J., eds., Raven Press, New York, pp. 347–353.

    Google Scholar 

  • Holmes A., Hollon T. R., Liu Z., Sibley D. R., J. Dreiling, Gleason T. C., and Crawley, J. N. (2001) Dopamine D5 receptor null mutant mice show attenuated behavioral responses to a dopamine agonist. Behavioral Neuroscience 115, 1129–1144.

    Article  PubMed  CAS  Google Scholar 

  • Holmes A., Parmigiani S., Ferrari P. F., Palanza P., and Rodgers R. J. (2000) Behavioral profile of wild mice in the elevated plus-maze test for anxiety. Physiol. Behav. 71, 509–516.

    Article  PubMed  CAS  Google Scholar 

  • Holmes A. and Rodgers R. J. (1998) Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state? Pharmacol. Biochem. Behav. 60, 473–488.

    Article  PubMed  CAS  Google Scholar 

  • Holmes A. and Rodgers R. J. (1999) Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosci. Biobehav. Rev. 23, 971–980.

    Article  PubMed  CAS  Google Scholar 

  • Holmes A. and Rodgers R. J. (2001) Prior test experience abolishes the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test. Behav. Brain Res. 122, 159–167.

    Article  PubMed  CAS  Google Scholar 

  • Iismaa T. P. and Shine J. (1999) Galanin and galanin receptors. Results Probl. Cell Differ. 26, 257–291.

    PubMed  CAS  Google Scholar 

  • Kerr B. J., Cafferty W. B., Gupta Y. K., et al. (2000) Galanin knockout mice reveal nociceptive deficits following peripheral nerve injury. Eur. J. Neurosci. 12, 793–802.

    Article  PubMed  CAS  Google Scholar 

  • Khoshbouei H., Cecchi M., and Morilak D. A. (1999) Interactive effects of acute stress and yohimbine on anxiety as measured with the elevated plus-maze. Soc. Neurosci. Abs. 25, 2140.

    Google Scholar 

  • Kishimoto T., Radulovic J., Radulovic M., et al. (2000) Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat. Genet. 24, 415–419.

    Article  PubMed  CAS  Google Scholar 

  • Kiss A. and Jezova D. (1998) Stress and colchicine do not induce the release of galanin from the external zone of the median eminence. Histochem. J. 30, 569–575.

    Article  PubMed  CAS  Google Scholar 

  • Koegler F. H., York D. A., and Bray G. A. (1999) The effects on feeding of galanin and M40 when injected into the nucleus of the solitary tract, the lateral parabrachial nucleus, and the third ventricle. Physiol. Behav. 67, 259–267.

    Article  PubMed  CAS  Google Scholar 

  • Koob G. F. (1999) Corticotropin-releasing factor, norepinephrine, and stress. Biol. Psychiatry 46, 1167–1180.

    Article  PubMed  CAS  Google Scholar 

  • Kyrkouli S. E., Stanley B. G., and Leibowitz S. F. (1986) Galanin: stimulation of feeding induced by medial hypothalamic injection of this novel peptide. Eur. J. Pharmacol. 122, 159–160.

    Article  PubMed  CAS  Google Scholar 

  • Kyrkouli S. E., Stanley B. G., and Leibowitz S. F. (1992) Differential effects of galanin and neuropeptide Y on extracellular norepinephrine levels in the paraventricular hypothalamic nucleus of the rat: a microdialysis study. Life Sci. 51, 203–210.

    Article  PubMed  CAS  Google Scholar 

  • LeDoux J. (1998) Fear and the brain: where have we been, and where are we going? Biol. Psychiatry 44, 1229–1238.

    Article  PubMed  CAS  Google Scholar 

  • Lundberg J. M., Hedlund B., Anggard A., et al. (1982) Co-storage of peptides and classical transmitters in neurons, in Systemic Role of regulatory Peptides (Bloom S. R. and Polak J. M., eds.), Lindenlaub., Schattauer, Stuttgart, pp. 93–111.

    Google Scholar 

  • Makino S., Asaba K., Nishiyama M., and Hashimoto K. (1999) Decreased type 2 corticotropin-releasing hormone receptor mRNA expression in the ventromedial hypothalamus during repeated immobilization stress. Neuroendocrinology 70, 160–167.

    Article  PubMed  CAS  Google Scholar 

  • Mathis C., Paul S. M., and Crawley J. N. (1995) Characterization of benzodiazepine-sensitive behaviors in the A/J and C57BL/6J inbred strains of mice. Behav. Genet. 24, 171–180.

    Article  Google Scholar 

  • Mazarati A. M., Halaszi E., and Telegdy G. (1992) Anticonvulsive effects of galanin administered into the central nervous system upon the picrotoxin-kindled seizure syndrome in rats. Brain Res. 589, 164–166.

    Article  PubMed  CAS  Google Scholar 

  • Mazarati A. M., Liu H., Soomets U., et al. (1998) Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus. J. Neurosci. 18, 10,070–10,077.

    CAS  Google Scholar 

  • Mazarati A. M., Hohmann J. G., Bacon A., et al. (2000) Modulation of hippocampal excitability and seizures by galanin. J. Neurosci. 20, 6276–6281.

    PubMed  CAS  Google Scholar 

  • McDonald M. P., Gleason T. C., Robinson J. K., and Crawley J. N. (1998) Galanin inhibits performance on rodent memory tasks. Ann. N. Y. Acad. Sci. 863, 305–322.

    Article  PubMed  CAS  Google Scholar 

  • Melander T., Hökfelt T., and Rökaeus Å. (1986) Distribution of galanin-like immunoreactivity in the rat central nervous system. J. Comp. Neurol. 248, 475–517.

    Article  PubMed  CAS  Google Scholar 

  • Melander T., Köhler C., Nilsson S., et al. (1988) Autoradiographic quantitation and anatomical mapping of 125I-galanin binding sites in the rat central nervous system. J. Comp. Neurol. 1, 213–233.

    CAS  Google Scholar 

  • Miller M. A., Kolb P. E., and Raskind M. A. (1997) GALR1 galanin receptor mRNA is co-expressed by galanin neurons but not cholinergic neurons in the rat basal forebrain. Brain Res. Mol. Brain Res. 52, 121–129.

    Article  PubMed  CAS  Google Scholar 

  • Möller C., Sommer W., Thorsell A., and Heilig M. (1999) Anxiogenic-like action of galanin after intra-amygdala administration in the rat. Neuropsychopharmacology 21, 507–512.

    Article  PubMed  Google Scholar 

  • Mufson E. J., Kahl U., Bowser R., Mash D. C., Kordower J. H., and Deecher D. C. (1998) Galanin expression within the basal forebrain in Alzheimer’s disease. Comments on therapeutic potential. Ann. N.Y. Acad. Sci. 863, 291–304.

    Article  PubMed  CAS  Google Scholar 

  • Narvaez J. A., Diaz-Cabiale Z., Hedlund P.B., et al. (2000) The galanin receptor antagonist M40 blocks the central cardiovascular actions of the galanin N-terminal fragment (1–15). Eur. J. Pharmacol. 399, 197–203.

    Article  PubMed  CAS  Google Scholar 

  • Nishibori M., Oishi R., Itoh Y., and Saeki K. (188) Galanin inhibits noradrenaline-induced accumulation of cyclic AMP in the rat cerebral cortex. J. Neurochem. 51, 1953–1955.

    Google Scholar 

  • O’Neal H. A., Van Hoomissen J. D., Holmes P. V., and Dishman R. K. (2001) Prepro-galanin messenger RNA levels are increased in rat locus coeruleus after treadmill exercise training. Neurosci. Lett. 299, 69–72.

    Article  PubMed  CAS  Google Scholar 

  • Perez S. E., Wynick D., Steiner R. A., and Mufson E. J. (2001) Distribution of galaninergic immunoreactivity in the brain of the mouse. J. Comp. Neurol. 434, 158–185.

    Article  PubMed  CAS  Google Scholar 

  • Pieribone V. A., Xu Z. Q., Zhang X., Grillner S., Bartfai T., and Hökfelt T. (1995) Galanin induces a hyperpolarization of norepinephrine-containing locus coeruleus neurons in the brainstem slice. Neuroscience 64, 861–874.

    Article  PubMed  CAS  Google Scholar 

  • Potter E. (1998) Cardiovascular actions of galanin. Ann. N. Y. Acad. Sci. 863, 170–174.

    Article  PubMed  CAS  Google Scholar 

  • Rökaeus Å., Melander T., Hökfelt T., et al. (1984) A galanin-like peptide in the central nervous system and intestine of the rat. Neurosci. Lett. 47, 161–166.

    Article  PubMed  Google Scholar 

  • Seutin V., Verbanck P., Massotte L., and Dresse A. (1989) Galanin decreases the activity of locus coeruleus neurons in vitro. Eur. J. Pharmacol. 164, 373–376.

    Article  PubMed  CAS  Google Scholar 

  • Sevcik J., Finta E. P., and Illes P. (1993) Galanin receptors inhibit the spontaneous firing of locus coeruleus neurones and interact with mu-opioid receptors. Eur. J. Pharmacol. 230, 223–230.

    Article  PubMed  CAS  Google Scholar 

  • Shih C. D., Chan S. H., and Chan J. Y. (1996) Participation of endogenous galanin in the suppression of baroreceptor reflex response by locus coeruleus in the rat. Brain Res. 20, 76–82.

    Article  Google Scholar 

  • Shimada T., Matsumoto K., Osanai M., Matsuda H., Terasawa K., and Watanabe H. (1995) The modified light ↔ dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs. Gen. Pharmacol. 26, 205–210.

    PubMed  CAS  Google Scholar 

  • Skofitsch G., Sills M. A., and Jacobowitz D. M. (1986) Autoradiographic distribution of 125I-galanin binding sites in the rat central nervous system. Peptides 7, 1029–1042.

    Article  PubMed  CAS  Google Scholar 

  • Smith G. W., Aubry J. M., Dellu F., et al. (1998) Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20, 1093–1102.

    Article  PubMed  CAS  Google Scholar 

  • Soares J., Holmes P. V., Renner K. J., Edwards G. L., Bunnell B. N., and Dishman R. K. (1999) Brain noradrenergic responses to footshock after chronic activity-wheel running. Behav. Neurosci. 113, 558–566.

    Article  PubMed  CAS  Google Scholar 

  • Steiner R. A., Hohmann J. G., Holmes A., et al. (2001) Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer’s disease. Proc. Natl. Acad. Sci. USA 98, 4184–4189.

    Article  PubMed  CAS  Google Scholar 

  • Stenzel-Poore M. P., Heinrichs S. C., Rivest S., Koob G. F., and Vale W. W. (1994) Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J. Neurosci. 14, 2579–2584.

    PubMed  CAS  Google Scholar 

  • Sweerts B.W., Jarrott B., and Lawrence A. J. (1999) Expression of preprogalanin mRNA following acute and chronic restraint stress in brains of normotensive and hypertensive rats. Brain Res. Mol. Brain Res. 69, 113–123.

    Article  PubMed  CAS  Google Scholar 

  • Timpl P., Spanagel R., Sillaber I., et al. (1998) Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor. Nat. Genet. 19, 162–166.

    Article  PubMed  CAS  Google Scholar 

  • Tjurmina O. A., Goldstein D. S., Palkovits M., and Kopin I. J. Alpha2-adrenoceptor-mediated restraint of norepinephrine synthesis, release, and turnover during immobilization in rats. Brain Res. 826, 243–252.

  • Tsuda K., Yokoo H., and Goldstein M. (1989) Neuropeptide Y and galanin in norepinephrine release in hypothalamic slices. Hypertension 14, 81–86.

    PubMed  CAS  Google Scholar 

  • Tsuda K., Goldstein M., and Masuyama Y. (1990) Neuropeptide Y and galanin enhance the inhibitory effects of clonidine on norepinephrine release from medulla oblongata of rats. Am. J. Hypertens. 3, 800–802.

    PubMed  CAS  Google Scholar 

  • Tsuda K., Tsuda S., Nishio I., Masuyama Y., and Goldstein M. (1992) Modulation of norepinephrine release by galanin in rat medulla oblongata. Hypertension 20, 361–366.

    PubMed  CAS  Google Scholar 

  • van Megen H. J., Westenberg H. G., den Boer J. A., and Kahn R. S. (1995) Cholecystokinin in anxiety. Eur. Neuropsychopharmacol. 6, 263–280.

    Google Scholar 

  • Venault P., Jacquot F., Save E., Sara S., and Chapouthier G. (1993) Anxiogenic-like effects of yohimbine and idazoxan in two behavioral situations in mice. Life Sci. 52, 639–645.

    Article  PubMed  CAS  Google Scholar 

  • Weiss J. M., Bonsall R. W., Demetrikopoulos M. K., Emery M. S., and West C. H. Galanin: a significant role in depression? Ann. N. Y. Acad. Sci. 863, 364–382.

  • Wiesenfeld-Hallin Z., Villar M. J., and Hökfelt T. (1989) The effects of intrathecal galanin and C-fiber stimulation on the flexor reflex in the rat. Brain Res. 486, 205–213.

    Article  PubMed  CAS  Google Scholar 

  • Wiesenfeld-Hallin Z., Xu X. J., Villar M. J., and Hökfelt T. (1990) Intrathecal galanin potentiates the spinal analgesic effect of morphine: electrophysiological and behavioural studies. Neurosci. Lett. 109, 217–221.

    Article  PubMed  CAS  Google Scholar 

  • Wrenn C. C. and Crawley J. N. (2001) Pharmacological evidence supporting a role for galanin in cognition and affect. Prog. Neuropsychopharmacol. Biol. Psychiatry 25, 283–299.

    Article  PubMed  CAS  Google Scholar 

  • Xu X. J., Hökfelt T., Bartfai T., and Wiesenfeld-Hallin Z. (2000) Galanin and spinal nociceptive mechanisms: recent advances and therapeutic implications. Neuropeptides 34, 137–147.

    Article  PubMed  CAS  Google Scholar 

  • Xu Z. Q., Shi T. J., and Hökfelt T. (1998a) Galanin/GMAP-and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and -R2 receptors. J. Comp. Neurol. 392, 227–251.

    Article  PubMed  CAS  Google Scholar 

  • Xu Z. Q., Zhang X., Pieribone V. A., Grillner S., and Hökfelt T. (1998b) Galanin-5-hydroxytryptamine interactions: electrophysiological, immunohistochemical and in situ hybridization studies on rat dorsal raphe neurons with a note on galanin R1 and R2 receptors. Neuroscience 87, 79–94.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section on Behavioral Neuropharmacology, National Institute of Mental Health, NIH, 20892-1375, Bethesda, MD, USA

    Andrew Holmes, Rebecca J. Yang & Jacqueline N. Crawley

Authors
  1. Andrew Holmes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rebecca J. Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jacqueline N. Crawley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew Holmes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Holmes, A., Yang, R.J. & Crawley, J.N. Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice. J Mol Neurosci 18, 151–165 (2002). https://doi.org/10.1385/JMN:18:1-2:151

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/JMN:18:1-2:151

Index Entries

Search

Navigation